Ms. Webb was appointed as Senior Vice President of Investor Relations in March of 2022. She brings more than 20 years of experience to her role. Most recently, she served as Vice President of Investor Relations at Rubius Therapeutics. Previously, she was responsible for heading investor relations at Radius Health and Genfit. During her time at Roche Investor Relations, Ms. Webb led Investor Relations activities for Roche Diagnostics. She also held business development roles at Roche Molecular Diagnostics and Morphochem. Earlier in her career, Ms. Webb spent more than a decade in Europe managing and leading investments in the healthcare sector at financial institutions such as BB Biotech-Bellevue Asset Management, Cantrade-UBS and Lombard Odier. Ms. Webb has a Masters in Business Administration from the University of Southern California and an undergraduate degree in Economics from Bogazici University in Istanbul, Turkey. She is also a CFA Charterholder.